rs472197
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001278356.2(FRS2):c.-122+868G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.6 in 151,986 control chromosomes in the GnomAD database, including 28,972 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.60 ( 28972 hom., cov: 32)
Consequence
FRS2
NM_001278356.2 intron
NM_001278356.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.62
Publications
2 publications found
Genes affected
FRS2 (HGNC:16971): (fibroblast growth factor receptor substrate 2) Enables fibroblast growth factor receptor binding activity and neurotrophin TRKA receptor binding activity. Involved in negative regulation of cardiac muscle cell differentiation. Acts upstream of or within fibroblast growth factor receptor signaling pathway. Located in adherens junction. Biomarker of renal cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.814 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.599 AC: 91024AN: 151868Hom.: 28926 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
91024
AN:
151868
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.600 AC: 91138AN: 151986Hom.: 28972 Cov.: 32 AF XY: 0.595 AC XY: 44172AN XY: 74264 show subpopulations
GnomAD4 genome
AF:
AC:
91138
AN:
151986
Hom.:
Cov.:
32
AF XY:
AC XY:
44172
AN XY:
74264
show subpopulations
African (AFR)
AF:
AC:
34110
AN:
41508
American (AMR)
AF:
AC:
7856
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
AC:
2060
AN:
3464
East Asian (EAS)
AF:
AC:
3271
AN:
5150
South Asian (SAS)
AF:
AC:
3232
AN:
4816
European-Finnish (FIN)
AF:
AC:
4643
AN:
10520
Middle Eastern (MID)
AF:
AC:
164
AN:
294
European-Non Finnish (NFE)
AF:
AC:
34232
AN:
67954
Other (OTH)
AF:
AC:
1220
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1722
3444
5167
6889
8611
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
742
1484
2226
2968
3710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2176
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.